Publikation:

Human 3D In Vitro Models for Developmental Neurotoxicity

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2018

Autor:innen

Smirnova, Lena

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

URI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Beitrag zu einem Sammelband
Publikationsstatus
Published

Erschienen in

SLIKKER, William, ed. and others. Handbook of Developmental Neurotoxicology. Second edition. London: Academic, 2018, pp. 163-172. ISBN 978-0-12-809405-1. Available under: doi: 10.1016/B978-0-12-809405-1.00014-6

Zusammenfassung

Developmental neurotoxicity (DNT) testing of industrial chemicals is an increasingly perceived societal need in light of strong increases in neurodevelopmental disorders including autism. The current testing approach for DNT in vivo does not satisfy these needs because despite enormous costs and animal use, there appears to be limited predictivity for its health effects in humans. The Center for Alternatives to Animal Testing (CAAT) in the United States and Europe along with its partners has steered a process of developing in vitro strategies for DNT, which is summarized here. This process has prioritized models, cellular key events, reference compounds, and others. This shaped a 3DNT approach, which aims to employ three-dimensional (3D) microphysiological models such as an induced pluripotent stem cells–derived mini-brain model from our laboratory. These complex models have to be complemented with, favorably 3D, models of homogenous cell models for pathway identification; an example of a 3D dopaminergic neurons (LUHMES) model is given. The human mini-brain model offers opportunities beyond studying developmental effects. It is also undergoing further amendments such as the addition of microglia and a blood–brain barrier. A major recent breakthrough showed that the model could be frozen for stockpiling and transport. This enables us to make the model readily available via commercial vendors. For this purpose, a Johns Hopkins spin-off biotech company, Organome LLC, was formed.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

neurodevelopment; brain; cell culture; organoids; spheroids; microphysiological systems; mini-brain

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690SMIRNOVA, Lena, Thomas HARTUNG, 2018. Human 3D In Vitro Models for Developmental Neurotoxicity. In: SLIKKER, William, ed. and others. Handbook of Developmental Neurotoxicology. Second edition. London: Academic, 2018, pp. 163-172. ISBN 978-0-12-809405-1. Available under: doi: 10.1016/B978-0-12-809405-1.00014-6
BibTex
@incollection{Smirnova2018Human-41991,
  year={2018},
  doi={10.1016/B978-0-12-809405-1.00014-6},
  title={Human 3D In Vitro Models for Developmental Neurotoxicity},
  edition={Second edition},
  isbn={978-0-12-809405-1},
  publisher={Academic},
  address={London},
  booktitle={Handbook of Developmental Neurotoxicology},
  pages={163--172},
  editor={Slikker, William},
  author={Smirnova, Lena and Hartung, Thomas}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/41991">
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/41991"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-04-10T08:44:17Z</dc:date>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Hartung, Thomas</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Hartung, Thomas</dc:creator>
    <dc:creator>Smirnova, Lena</dc:creator>
    <dc:language>eng</dc:language>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-04-10T08:44:17Z</dcterms:available>
    <dc:contributor>Smirnova, Lena</dc:contributor>
    <dcterms:issued>2018</dcterms:issued>
    <dcterms:abstract xml:lang="eng">Developmental neurotoxicity (DNT) testing of industrial chemicals is an increasingly perceived societal need in light of strong increases in neurodevelopmental disorders including autism. The current testing approach for DNT in vivo does not satisfy these needs because despite enormous costs and animal use, there appears to be limited predictivity for its health effects in humans. The Center for Alternatives to Animal Testing (CAAT) in the United States and Europe along with its partners has steered a process of developing in vitro strategies for DNT, which is summarized here. This process has prioritized models, cellular key events, reference compounds, and others. This shaped a 3DNT approach, which aims to employ three-dimensional (3D) microphysiological models such as an induced pluripotent stem cells–derived mini-brain model from our laboratory. These complex models have to be complemented with, favorably 3D, models of homogenous cell models for pathway identification; an example of a 3D dopaminergic neurons (LUHMES) model is given. The human mini-brain model offers opportunities beyond studying developmental effects. It is also undergoing further amendments such as the addition of microglia and a blood–brain barrier. A major recent breakthrough showed that the model could be frozen for stockpiling and transport. This enables us to make the model readily available via commercial vendors. For this purpose, a Johns Hopkins spin-off biotech company, Organome LLC, was formed.</dcterms:abstract>
    <dcterms:title>Human 3D In Vitro Models for Developmental Neurotoxicity</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen